Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epstein-Barr virus gp42 antibodies reveal sites of vulnerability for receptor binding and fusion to B cells
Wei Bu, Ashish Kumar, Nathan L. Board, et al.
Immunity (2024) Vol. 57, Iss. 3, pp. 559-573.e6
Open Access | Times Cited: 11

Showing 11 citing articles:

Multiple sclerosis and infection: history, EBV, and the search for mechanism
Elliott D. SoRelle, Micah A. Luftig
Microbiology and Molecular Biology Reviews (2025)
Closed Access | Times Cited: 1
Potent human monoclonal antibodies targeting Epstein-Barr virus gp42 reveal vulnerable sites for virus infection
Gexin Zhao, Xin-Yan Fang, Guo‐Long Bu, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 5, pp. 101573-101573
Open Access | Times Cited: 4
High IgG titers against EBV glycoprotein 42 correlate with lower risk of nasopharyngeal carcinoma
Benjamin E. Warner, Kathy H.Y. Shair
Journal of Clinical Investigation (2025) Vol. 135, Iss. 4
Open Access
Knowledge mapping of childhood infectious mononucleosis: a bibliometric analysis for the twenty-first century
Zhengjiu Cui, Jinjuan Wang, Juanjuan Diao, et al.
Journal of Health Population and Nutrition (2025) Vol. 44, Iss. 1
Open Access
A gH/gL-encoding replicon vaccine elicits neutralizing antibodies that protect humanized mice against EBV challenge
Kristina R. Edwards, Harman Malhi, Karina Schmidt, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 2
Multivalent MVA-vectored vaccine elicits EBV neutralizing antibodies in rhesus macaques that reduce EBV infection in humanized mice
Gabriela M. Escalante, Ivana Gabriela Reidel, Lorraine Z. Mutsvunguma, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Research landmarks on the 60th anniversary of Epstein-Barr virus
Lan‐Yi Zhong, Chu Xie, Lele Zhang, et al.
Science China Life Sciences (2024)
Closed Access | Times Cited: 2
A Comparison of Polyvalent Passive Immunoprotection from Antibodies with Different Immunity Models of Live or Inactivated Vibrio fluvialis in Fish
Huihui Xiao, Pan Cui, Jing Chen, et al.
Fishes (2024) Vol. 9, Iss. 8, pp. 302-302
Open Access | Times Cited: 1
In-depth analysis of serum antibodies against Epstein-Barr virus lifecycle proteins, and EBNA1, ANO2, GlialCAM and CRYAB peptides in patients with multiple sclerosis
N. A. Vasilenko, Maria P. Tieck, Tanja Michel, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Surface different charge ligands for modulating selenium nanoparticles formation and activating the interaction with proteins for effective anti-Herpes simplex virus l infection
Xu Chen, Yue Jian, Xinhua Xu, et al.
Nanotechnology (2024) Vol. 36, Iss. 6, pp. 065101-065101
Closed Access
EB病毒糖蛋白中和抗体研究进展
Junping Hong, L. Zhong, Wanlin Zhang, et al.
Scientia Sinica Vitae (2024)
Closed Access
Page 1

Scroll to top